Author/Creator: Selkoe, D.J. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Selkoe, D.J.

1. P32 Phase III studies of crenezumab in early (prodromal-to-mild) Alzheimers disease (CREAD/CREAD2): Biomarker results. Issue 4 (April 2020)

Authors:: Bittner, T.; Duning, T.; Rabe, C.; Clayton, D.; Quartino, A.; Bohorquez, S. Sanabria; Hu, N.; Rabbia, M.; Shimizu, H.; Eichenlaub, U.; Smith, J.; Honigberg, L.; Selkoe, D.J.; Ostrowitzki, S.
Journal:: Clinical neurophysiology
Issue:: Volume 131:Issue 4(2020:Apr.)
Page Start:: e194
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. The APP family of proteins: similarities and differences. (20th March 2007)

Authors:: Walsh, D.M.; Minogue, A.M.; Sala Frigerio, C.; Fadeeva, J.V.; Wasco, W.; Selkoe, D.J.
Journal:: Biochemical Society transactions
Issue:: Volume 35:Number 2(2007)
Page Start:: 416
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. The role of cell-derived oligomers of Aβ in Alzheimer's disease and avenues for therapeutic intervention. (26th October 2005)

Authors:: Walsh, D.M.; Klyubin, I.; Shankar, G.M.; Townsend, M.; Fadeeva, J.V.; Betts, V.; Podlisny, M.B.; Cleary, J.P.; Ashe, K.H.; Rowan, M.J.; Selkoe, D.J.
Journal:: Biochemical Society transactions
Issue:: Volume 33:Number 5(2005)
Page Start:: 1087
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗